Good news for men—potentially—but bad news for patent librarians.
Millennium Predictive Medicine of Massachusetts has filed a patent (WO 01/60860)
on “novel genes” for identifying, assessing, preventing and treating prostate
cancer. It says the genes change as a patient develops prostate cancer, and so
provide an early warning of the disease. This should improve the chances for
therapy or surgery. But the gene sequences are so long that the patent fills 14
box files—equivalent to several hundred conventional paper patents.
More from New Scientist
Explore the latest news, articles and features
Technology
Google shouldn’t be pressuring schools to use its AI
91ɫÇéƬ
Technology
Australia’s social media ban faces high court challenge
News
Technology
The nuclear waste repository in Finland designed to outlast modern civilisation
Features
Technology
How did the biggest crypto heist in history just happen?
News
Popular articles
Trending New Scientist articles